NCT00636285View on ClinicalTrials.gov

Safety and Pharmacokinetics Study in Adults for the Prevention of S. Epidermidis Infection in Low Birth Weight Infants

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

September 30, 2001

Study Completion Date

November 30, 2001

Conditions
Staphylococcal Sepsis
Interventions
DRUG

Placebo

Placebo

DRUG

BSYX-A110

BSYX-A110, Dosed intravenously, 3 mg/kg

DRUG

BSYX-A110

BSYX-A110, Dosed intravenously, 10 mg/kg

Trial Locations (1)

77030

Baylor College of Medicine, Houston

Sponsors
All Listed Sponsors
lead

Biosynexus Incorporated

INDUSTRY

NCT00636285 - Safety and Pharmacokinetics Study in Adults for the Prevention of S. Epidermidis Infection in Low Birth Weight Infants | Biotech Hunter | Biotech Hunter